The innovative drug concept has repeatedly strengthened, and Qianhong Bio-pharma has surged to the limit
36Kr learned that as of the time of publication, the innovative drug concept has repeatedly strengthened, Qianhong Bio-pharma surged to the limit, Thalys, JLPC, C&Y Pharmaceutical, and Haikang all hit the daily limit, while HWPC rose over 10%, reaching a historical high
Source: 36Kr The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments